ClinicalTrials.gg
RecruitingNCT06337201Updated Mar 29, 2024

A Digital Life Story to Support Person-centred Care for Older Adults With Dementia Perspectives

An observational study in Cognitive Impairment and Dementia, sponsored by Blekinge Institute of Technology. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-29.

Sponsored by Blekinge Institute of Technology · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Started Aug 2022; still recruiting 4 years 2 months later.
Study type
Observational
Model
Other
Time perspective
Other
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Person-centred care can be supported when healthcare professionals access and actively use the information recorded in a life story. Active use of the life story can create security for a person with dementia and their carers. The written life story describes the person and their life experiences, which can define the person's identity. National guidelines for care and nursing in dementia and Blekinge's regional guidelines emphasise the importance of care and nursing for people with dementia, which should be given with a person-centred approach, where the life story becomes a tool for healthcare professionals. Research shows that a life story can be designed in several ways. For example, in book form, as a brochure, collage, memory box or electronically. The life story is also intended as a tool for healthcare professionals to create security and facilitate communication with the individual. As more and more older adults are using computers and tablets as assistive devices, and it is also becoming more common for healthcare professionals to use, for example, tablets as assistive devices in nursing care, the life story could be shared in digital form as an application and become a living document.

Overall aim: To test an application for the life story with the intention of supporting person-centred care for older adults with dementia and to test whether the application can replace the written completion document. Study I: Exploring the research area of the life story in digital form. Study II: Focus group interviews with healthcare professionals. Study III: Test the application, Min Memoria. Study IV: Observations on the use of the application.

02

Conditions studied

  • Cognitive Impairment
  • Dementia
03

In context

Cognitive Dysfunction

3,872 studies on the registry are indexed under Cognitive Dysfunction; 1,119 are open to participants now.

This study's planned enrollment of 30 is below the median of 150 across 997 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Blekinge Institute of Technology is the lead sponsor of 14 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthcare professionals working in daycare center and residential care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthcare professionals using a life story in daily care.

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthcare professionals working in daycare center and residential care.

    Device: Test of the application Min Memoria

Interventions

  • DeviceTest of the application Min Memoria

    Focus group interviews will be conducted to reach healthcare professionals' experiences using a written life story in daily care. Then, the information from the written life story will be transferred to the application, and the healthcare professionals will test a digital life story (the application) in daily care instead. Observation studies will be conducted to observe the use of the digital life story. What can be seen in the communication and the interaction, and in what situations is the digital life story used?

06

What researchers measure

Primary outcomes

  1. Healthcare professionals' experiences using a written life story in the daily care of older adults with dementia

    Focus group interviews

    Time frame: From October 2023 - August 2024

  2. Data on the use of a digital life story tool.

    Explore the usability, accessibility and positive and negative effects on daily care. Data will be collected through a survey with healthcare professionals (participants).

    Time frame: September 2024 - August 2025

  3. Observation when using a digital life story

    Data will be collected through non-participant observations. Observing communication and interactions between the healthcare professionals and the older adults when using the digital tool.

    Time frame: September 2025 - December 2026

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data supporting this study's findings will be available on request from the corresponding author (Helén Dellkvist). The data are not publicly available due to privacy or ethical restrictions.

Supporting information: Study protocol, Clinical study report, Analytic code

Time frame: From when each sub-study is publiced and onwards.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2022 (actual). Primary completion is estimated for Jan 2026, 41 months after the start.

Of 504 non-industry observational studies under Cognitive Dysfunction, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 118. This study's planned 41 months is below that.

Counting every sponsor, half of 543 studies reached it within 47 months; a quarter within 21 and three quarters within 118.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2024
First posted
Mar 29, 2024
StartActual
Aug 15, 2022
Primary completionEst.
Jan 2026
CompletionEst.
Jun 2027
Last update
Mar 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06337201
Lead sponsor
Blekinge Institute of Technology
Responsible party
Sponsor
First posted
Mar 29, 2024
Start date
Aug 15, 2022
Primary completion
Jan 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 29, 2024

Study contacts

Helén D Dellkvist, PhD student
Contact
helen.dellkvist@bth.se
+46732313417
Peter Anderberg, Professor
Contact
peter.anderberg@bth.se
+46734223736

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion